Cytokinetics (NASDAQ:CYTK) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Cytokinetics missed estimated earnings by 8.51%, reporting an EPS of $-1.02 versus an estimate of $-0.94.
Revenue was down $5.40 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.48 which was followed by a 3.15% increase in the share price the next day.
Here's a look at Cytokinetics's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.84 | -0.76 | -0.65 | -0.58 |
| EPS Actual | -0.36 | -0.95 | -0.86 | -0.66 |
| Revenue Estimate | 6.20M | 6.42M | 5.45M | 6.58M |
| Revenue Actual | 55.60M | 5.44M | 2.84M | 6.55M |
To track all earnings releases for Cytokinetics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
